Table 2.
Examination of Symptom Frequency and Percentage Across Early, Mid, and Late Infection for Those With Confirmed Positive SARS-CoV-2 Infection as a Means of Assessing Temporality of Symptoms
| Symptoms in Positive Cases, No. (%) | |||||
|---|---|---|---|---|---|
| Early Infection (n = 77) | Midinfection (n = 84) | Late Infection (n = 155) | P | All (n = 316), No. (%) | |
| Cough | 63 (82) | 62 (74) | 134 (86) | .06 | 259 (82) |
| Fever | 51 (66) | 58 (69) | 103 (66) | .93 | 212 (67) |
| Dyspnea | 31 (40) | 42 (50) | 71 (46) | .47 | 144 (46) |
| Headache | 46 (60) | 59 (70) | 86 (56) | .08 | 191 (60) |
| Diarrhea | 27 (35) | 27 (32) | 67 (43) | .20 | 121 (38) |
| Rhinorrhea | 13 (17) | 14 (17) | 25 (16) | <.99 | 52 (16) |
| Sore throat | 20 (26) | 31 (37) | 64 (42) | .81 | 115 (36) |
| Fatigue | 49 (64) | 62 (74) | 84 (54) | .01* | 195 (62) |
| Myalgia | 44 (57) | 50 (60) | 71 (46) | .08 | 165 (52) |
| Sinus congestion | 21 (27) | 25 (30) | 37 (24) | .59 | 83 (26) |
| Anosmia | 19 (25) | 27 (32) | 56 (36) | .21 | 102 (32) |
Significance was measured using the Fisher exact test.
*Statistically significant difference between mid and late infection time points.